1.0 INTENDED USE
The reagent is intended for the quantitative
determination of Glucose in serum or plasma.
2.0 BACKGROUND
2.1 METHOD AND HISTORY
Enzymatic methods for the determination of glucose were described by Keilin and Hartree (10.1). Passey, et. al. (10.3) have reviewed 10 glucose methods and have used the hexokinase method as the reference procedure.
2.2 TEST PRINCIPLE
Glucose is converted to glucose‑6‑phosphate
(G‑6‑P) by hexokinase (HK) in the presence of adenosine
triphosphate (ATP). G‑6‑P is
converted to 6‑phosphogluconate and NADH in the presence of glucose‑6‑phosphate
dehydrogenase (G‑6‑PDH) and nicotinamide adenine dinucleotide (NAD)
and the increase in optical density at 340 nm is measured.
HK
Glucose +
ATP ‑‑‑‑‑> G‑6‑P + ADP
G‑6‑PDH
G‑6‑P
+ NAD+ ‑‑‑‑‑‑‑-------->
6‑phosphogluconate + NADH + H+
NADH causes an increase in absorbance at 340 nm which is
directly proportional to the concentration of glucose in the sample.
2.3 CLINICAL SIGNIFICANCE (10.4)
Elevated levels of glucose (hyperglycemia) are found in
uncontrolled diabetes mellitus, hyperthyroidism, hyperadrenalism, uremia and
bacterial or viral infections.
Low levels of glucose (hypoglycemia) are found in certain
adrenal and pituitary disorders, and in cases of high levels of insulin or
other antidiabetic drugs.
3.0 SPECIMEN COLLECTION AND HANDLING
3.1 PATIENT PREPARATION
The
patient should be fasting for 12 hours prior to specimen collection.
3.2 SPECIMEN COLLECTION.
Fresh, clear, unhemolyzed serum is the preferred
specimen. Plasma may be used if citrate,
oxalate, heparin or EDTA are employed as the anticoagulant. Hemolyzed samples must not be used since
erythrocytes contain glucose-6-phosphate which is an intermediate product in
this reaction.
Use a
standard venipuncture tube to draw patient sample.
The amount of sample required will depend on the analyzer
used. The amount of serum required is in
the range of 5-25 µl. Call Biotron's
technical service department at 1-800-595-8766 for the recommended sample
volume for your analyzer.
Record the patient's name, date and time of sample
collection and preparation.
3.3 SPECIMEN STORAGE
Samples must be separated within 30 minutes of collection
as glycolysis occurs in whole blood at a rate of 7% per hour.(10.4)
Serum samples may be stored refrigerated (2°-8° C) for 1
week , or frozen (-20° C) for 1 month
prior to analysis. Frozen samples should
be thawed at room temperature and mixed thoroughly before analysis. Thawed samples should not be refrozen. (10.4)
It is recommended that testing be done as soon as
possible after sample collection and preparation. If testing cannot occur immediately, store
the sample properly using the guidelines above.
4.0 MATERIALS (10 X 10 ml)
(6 X 50 ml)
(6 X 100 ml)
(6 X 500 ml)
Reagents necessary for the determination of glucose are
included in the kit.
4.1 GLUCOSE (HK) REAGENT
Each vial contains, after reconstitution with deionized
water:
phosphate buffer 100
mM
magnesium chloride 2mM
ATP 4mM
NAD 2mM
HK (yeast) 2000
U/L
G‑6‑PDH
(L.mesenteroides) 4000
U/L
4.2 WARNINGS AND PRECAUTIONS
For In Vitro Diagnostic Use. Never pipette by mouth. Exercise the normal precautions required for
handling all laboratory reagents.
4.3 REAGENT PREPARATION
4.3.1
The working reagent is prepared by adding 10 ml of
deionized water to each glucose reagent vial.
Replace the rubber stopper and allow 5 minutes for reconstitution. Swirl gently until the contents of the vial
are completely dissolved. Record the
date and time of reconstitution.
4.3.2
The working reagent is prepared by adding 50 ml of
deionized water to each glucose reagent vial.
Replace the rubber stopper and allow 5 minutes for reconstitution. Swirl gently until the contents of the vial
are completely dissolved. Record the
date and time of reconstitution.
4.3.3
The working reagent is prepared by adding 100 ml of
deionized water to each glucose reagent vial.
Replace the rubber stopper and allow 5 minutes for reconstitution. Swirl gently until the contents of the vial
are completely dissolved. Record the
date and time of reconstitution.
4.3.4
The working reagent is prepared by adding 500 ml of
deionized water to each glucose reagent vial.
Replace the rubber stopper and allow 5 minutes for reconstitution. Swirl gently until the contents of the vial
are completely dissolved. Record the
date and time of reconstitution.
4.4 STORAGE AND
STABILITY
When stored at 2°-8°C unopened reagents are stable until
the expiration date printed on the label.
The working reagent is stable for 30 days at 2°-8° C.
4.5 ADDITIONAL MATERIALS REQUIRED
4.5.1 Spectrophotometer
or colorimeter capable of reading absorbance at 340 nm.
4.5.2 1 cm cuvettes
or a flow cell capable of transmitting light at 340 nm.
4.5.3 Test tubes
capable of holding 3 ml.
4.5.4 Pipettes
capable of delivering 2.5 ml and 25 µl.
4.5.5 Deionized or
distilled water for preparing the reagent blank.
4.5.6 Timer for a 5
minute or 10 minute incubation.
4.5.7 Constant
temperature source which can be adjusted to 37° C.
4.5.8 Calibrator
4.5.9 Normal and
abnormal controls for quality control.
5.0 TEST PROCEDURE
The
following is a general procedure for use on a manual instrument.
5.1 PROCEDURE CONDITIONS
Wavelength 340
nm
Temperature 37°
C, or 18‑26° C
Pathlength 1.0
cm
Mode endpoint
Reaction time 5
min at 37° C
10
min at 18‑26° C
Sample volume 25
µl
Reagent volume 2.5
ml
Total volume 2.525
ml
Sample to reagent
ratio 1/100
5.2 INSTRUMENT
Any instrument capable of reading absorbance accurately
with a sensitivity of 0.001 absorbance at 340 nm may be used. The band width should be 10 nm or less, stray
light 0.5% or less, and the wavelength accuracy within 2 nm.
5.3 CALIBRATION
The Glucose (HK) assay is calibrated by referencing the absorbance
of the unknown sample to the absorbance of the calibrator.
5.4 PROCEDURE
5.4.1 Prepare the
required volume of working reagent. (See
4.3 Reagent Preparation Section.)
5.4.2 Into separate
test tubes pipette 25 µl of distilled water, calibrator, or serum to be
assayed.
5.4.3 Add 2.5 ml of
working reagent to each test tube and mix.
5.4.4 Following
incubation for 5 minutes at 37° C in a heat block or 10 minutes at 18‑26°
C (room temperature), determine the absorbance of the calibrator (As) and of each
serum (A) at 340 nm using the distilled water sample as the reagent blank.
5.5 CALCULATION AND RESULTS
A
Glucose
(mg/dl) = -‑‑‑‑- X concentration of calibrator
As
A =
absorbance of sample, As = absorbance of calibrator
Example:
.295
Glucose
(mg/dl) = --‑‑‑‑--- X 100 mg/dl = 83 mg/dl
.355
with A =
.295 and As = .355, concentration of calibrator = 100 mg/dl
6.0 INTERPRETATION OF RESULTS
6.1 EXPECTED VALUES (10.4)
The range of expected values in adults for fasting glucose using the glucose (HK) method is: 70-105 mg/dl
These values are suggested guidelines. It is recommended that each laboratory
establish the normal range for the area in which it is located.
6.2 MEDICAL ALERT VALUES
Each laboratory should establish low and high values
beyond which the patient would require immediate attention by a physician. If a "medical alert value" is
reached, always repeat the test to confirm the result and notify a physician if
the result is confirmed.
Reference
10.6 provides a discussion of some critical values.
6.3 LIMITATIONS OF PROCEDURE
6.3.1 High levels
of fructose in serum, as may occur in essential fructosuria or after excessive
ingestion of fruits, may produce falsely elevated glucose levels, i.e., 200mg
of fructose will react as 1mg of glucose.
Greater than 500mg of fructose are inhibitory. (10.4)
6.3.2 Hemoglobin
itself is not an interfering substance, however, hemolyzed cells can release
enzymes which catabolize glucose as well as glucose-6-phosphate, the latter of
which is a reaction intermediate. This
effect is minimized when samples are stored in a refrigerator at 2°-8°C
especially in the presence of fluoride ion. (10.4)
6.3.3 A
comprehensive list of drugs and other substances which can affect the glucose
concentration in serum is given by Young. (10.5)
6.3.4 As with any
chemical reaction, users should be alert to the possible effect on results
caused by unknown interferences from medications or endogenous substances. All patient results should be evaluated in
light of the total clinical status of the patient.
6.3.5 Use of this
test has not been evaluated in neonatal hypoglycemia. Thus this test is not recommended for use
with neonatal (birth to 4 weeks) specimens.
7.0 QUALITY CONTROL
Standard practice for quality control should be applied
to this system. Commercially available
lyophilized controls can be used to monitor the daily acceptable
variations. Normal and abnormal controls
should be assayed at the beginning of each run of patient samples, whenever a
new reagent or a different lot number is being used, and following any system
maintenance.
A satisfactory level of performance is achieved when the
analyte values obtained are within the "acceptable range" established
by the laboratory.
8.0 CALIBRATION PROCEDURES
The Glucose (HK) assay is calibrated by referencing the
absorbance of the unknown sample to the absorbance of the calibrator. Refer to your instrument manual for more
details.
Calibration is required with the use of a new lot of
reagent, any system maintenance or whenever indicated by quality control data.
9.0 PERFORMANCE CHARACTERISTICS
9.1 PRECISION
The estimates of precision shown below were obtained from assays of human control serum.
Within-Run
In this
study, 15 replicates of 2 control sera were run.
Mean
(mg/dl) SD (mg/dl) CV
(%)
79 ± 0.57 0.73
309 ± 4.08 1.33
Between-Run
In this study, 5 runs were made, each run consisting of 5
replicates of 2 control sera.
Mean
(mg/dl) SD (mg/dl) CV
(%)
96 ± 1.42 1.49
332 ± 4.73 1.43
9.2 CORRELATION
A correlation study was done on the Technicon RA-500
system at 37° C comparing King Glucose (HK) method and a similar glucose (HK)
method. The samples range between 35
mg/dl and 559 mg/dl.
Number Regression Equation Correlation
of
Samples y=Biotron,
x=Comparative Coefficient
44 y = .987 x + .470 0.999
9.3 LINEARITY
This method is linear to 500 mg/dl. A sample with glucose beyond the linearity
limit should be diluted 1 to 1 with deionized water. Reassay the specimen and multiply the results
by 2.
10.0 REFERENCES
10.1 Keilin, D.,
Hartree, E.F., Biochem. J. 42,250 (1948).
10.2 United States
Department of Health, Education and Welfare, Food and Drug Administration. In vitro Diagnostic Products for Human Use,
Proposed Establishment of Product Class Standard for Detection or Measurement
of Glucose, Fed. Regist. 39, No. 126, 24136‑24147 (1974).
10.3 Passey, R.B.,
Gillum, R.L., Fuller, J.B., Urry, F.M., Giles, M.L., Evaluation and Comparison
of Ten Glucose Methods and the Reference Method Recommended in the Proposed
Product Class Standard (1974), Clin. Chem. 23, 131‑139 (1977).
10.4 Tietz, N.W.,
(ed.), Fundamentals of Clinical Chemistry, 2nd ed., W.B. Saunders Co., Toronto,
1213 (1982).
10.5 Young, D.S.,
Effects of Drugs on Clinical Laboratory Tests, 3rd ed., Washington DC, AACC
Press (1990).
10.6 G.J. Kost,
"Critical Limits for Urgent Clinician Notification at U.S. Medical
Centers"; JAMA, Feb. 2, 1990; Vol 263, No.5, p.704
Rev
10//99